Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: Findings from the PROTEKT US study, 2000?2001
  1. Home
  2. Publications
  3. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: Findings from the PROTEKT US study, 2000?2001

Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: Findings from the PROTEKT US study, 2000?2001

Author:
  • CSC Stratton
    C Stratton

Publisher website
Google Scholar
  • 1 April 2004
    • journal article
    • research article
    • Published by Elsevier in Clinical Therapeutics
    • Vol. 26  (4) , 522-530
    • DOI:10.1016/s0149-2918(04)90054-9
    • PMID:15189749
Abstract
No abstract available
Keywords
  • ANTIMICROBIALS
  • PATHOGENS
  • RESPIRATORY TRACT
  • BETA
  • LACTAM
  • VITRO ACTIVITY
  • ACTIVITY OF TELITHROMYCIN
  • PROTEKT
Cited by 7 articles
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.